Indication
Disseminated aspergillosis
Disseminated aspergillosis is a severe, life-threatening form of invasive fungal disease caused by *Aspergillus* species, most frequently *Aspergillus fumigatus*. Read more about Disseminated aspergillosis
1 drugs 1 manufacturers
Drugs that treat it
Common Disseminated aspergillosis therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDisseminated aspergillosis is a severe, life-threatening form of invasive fungal disease caused by *Aspergillus* species, most frequently *Aspergillus fumigatus*.
It primarily occurs in severely immunocompromised hosts, such as patients with prolonged neutropenia, hematologic malignancies, or hematopoietic stem cell and solid organ transplants, as well as those receiving intensive immunosuppressive therapy.
Pathophysiologically, fungal hyphae exhibit angioinvasion from a primary site—typically the lungs or paranasal sinuses—resulting in vascular thrombosis, tissue infarction, and hematogenous seeding across two or more noncontiguous organ systems.
Clinically, it manifests as refractory fever and rapid multiorgan decline, commonly involving metastatic foci in the central nervous system, skin, kidneys, liver, and bones.
- nih.gov
Disseminated aspergillosis is a severe, life-threatening form of invasive fungal disease caused by *Aspergillus* species, most frequently *Aspergillus fumigatus* It primarily occurs in severely immunocompromised hosts, such as patients with prolonged neutropenia, hematologic malignancies, or hematopoietic stem cell and solid organ transplants, as well as those receiving intensive immunosuppressive therapy Pathophysiologically, fungal hyphae exhibit angioinvasion from a primary site—typically the...
- nih.gov
Disseminated aspergillosis is a severe, life-threatening form of invasive fungal disease caused by *Aspergillus* species, most frequently *Aspergillus fumigatus* Pathophysiologically, fungal hyphae exhibit angioinvasion from a primary site—typically the lungs or paranasal sinuses—resulting in vascular thrombosis, tissue infarction, and hematogenous seeding across two or more noncontiguous organ systems Clinically, it manifests as refractory fever and rapid multiorgan decline, commonly involving ...
- cdc.gov
It primarily occurs in severely immunocompromised hosts, such as patients with prolonged neutropenia, hematologic malignancies, or hematopoietic stem cell and solid organ transplants, as well as those receiving intensive immunosuppressive therapy Clinically, it manifests as refractory fever and rapid multiorgan decline, commonly involving metastatic foci in the central nervous system, skin, kidneys, liver, and bones
Personalize your experience
Follow Disseminated aspergillosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.